Klaria Pharma Holding AB (publ.) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was SEK 0.228 million compared to SEK 6.54 million a year ago. Net loss was SEK 35.78 million compared to SEK 63.77 million a year ago.

Basic loss per share from continuing operations was SEK 0.18 compared to SEK 1.1 a year ago. Diluted loss per share from continuing operations was SEK 0.18 compared to SEK 1.1 a year ago.